ArticleMetabolites2022

Dolutegravir Discontinuation for Neuropsychiatric Symptoms in People Living with HIV and Their Outcomes after Treatment Change: A Pharmacogenetic Study.

Jessica Cusato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.